Novo Nordisk's next-gen weight loss drug outperforms Zepbound in new trial
Novo Nordisk reported that its experimental weight loss drug outperformed Zepbound in a recent clinical trial. The drug is being positioned as a potential successor to Wegovy.
Novo Nordisk says its potential Wegovy successor helped patients lose more weight than Zepbound in a major clinical trial.
READ NEXT
More on the wire
AI TLDR
A 2027 NFL mock draft projects the Dolphins selecting wide receiver Jeremiah Smith first overall. The draft analysis also suggests Arch Manning will be selected by the Cardinals.
FROM THE PUBLISHER
Plus, two teams earn 'A+' grades after superb offensive performances, and another 'F' makes its way into the discussion
AI TLDR
College football rankings saw a major shakeup after eight ranked teams lost in Week 4. Six new teams entered the top 25, with Iowa defeating Michigan and Texas maintaining its top ranking.